Literature DB >> 32174073

[Comparison of different transforaminal endoscope approaches in treatment of serious lumbar disc herniation].

Hu Yang1, Pengfei Li1, Nan Jia1, Jinxing Wang1, Xianhui Jin1.   

Abstract

OBJECTIVE: To investigate the difference between four transforaminal endoscopic approaches in the treatment of serious lumbar disc herniation.
METHODS: Between October 2010 and February 2015, a total of 122 patients with serious lumbar disc herniation were enrolled and treated with discectomy under transforaminal endoscope. The patients were divided into 4 groups according to the different approaches. The transforaminal endoscopic spine system (TESSYS) technology was used in group A (31 cases), Yeung endoscopic spine system (YESS) technology was used in group B (30 cases), improved transforaminal endoscopic access (ITEA) technology was used in group C (31 cases), and interlaminar dorsal access (IDA) technology was used in group D (30 cases). There was no significant difference in gender, age, disease duration, lesion segment, and preoperative visual analogue scale (VAS) score of low back pain, VAS score of bilateral lower extremities pain, Oswestry disability index (ODI), intervertebral height, lumbar curvature index (LCI), and disc degeneration grading between groups ( P>0.05). The removal volume of nucleus pulposus was compared; after operation, VAS score, ODI score, LCI, intervertebral height, and disc degeneration grading were used to evaluate the effectiveness.
RESULTS: The removal volumes of nucleus pulposus in groups A, B, C, and D were (3.6±0.9), (3.5±0.7), (4.6±1.0), (3.1±1.1) cm 3, respectively. There were significant differences between groups ( P<0.05). All incisions healed by first intention, and no early postoperative complications was found. All cases were followed up 12-35 months, with an average of 24 months. During follow-up, there was no recurrence of nucleus pulposus herniation, infection of intervertebral space, cerebrospinal fluid leakage, epidural hematoma, or other complications. At last follow-up, the VAS scores of low back pain and bilateral lower extremities pain, and ODI scores in each group significantly improved when compared with those before operation ( P<0.05); there was no significant difference in the scores and improvements between groups after operation ( P>0.05). At last follow-up, the disc degeneration grading in group B significantly improved when compared with that before operation ( P<0.05); there was no significant difference between groups ( P>0.05). At last follow-up, there was no significant difference in LCI of each group when compared with that before operation ( P>0.05); and there was no significant difference in LCI and loss value between groups ( P>0.05). There was no significant difference in the intervertebral height of the 4 groups at immediate after operation and last follow-up when compared with preoperative value ( P>0.05), and there was no significant difference between groups at immediate after operation and last follow-up ( P>0.05).
CONCLUSION: Application of transforaminal endoscope in the treatment of serious lumbar disc herniation has great clinical outcomes. The ITEA technology can obtain a wider field of view and be more convenient to find and remove the degenerative nucleus pulposus. However, the appropriate approach should be selected according to the symptoms and characteristics of lumbar disc herniation.

Entities:  

Keywords:  Discectomy; approach; minimally invasive surgery; serious lumbar disc herniation; transforaminal endoscope

Mesh:

Year:  2020        PMID: 32174073      PMCID: PMC8171653          DOI: 10.7507/1002-1892.201811005

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  21 in total

1.  Changes in the microhemodynamics of nerve root retraction in patients with lumbar spinal canal stenosis.

Authors:  Akira Dezawa; Kazutoshi Unno; Tomojiro Yamane; Hiroshi Miki
Journal:  Spine (Phila Pa 1976)       Date:  2002-12-15       Impact factor: 3.468

2.  Assessment of the learning curve for lumbar microendoscopic discectomy.

Authors:  Adrian M Nowitzke
Journal:  Neurosurgery       Date:  2005-04       Impact factor: 4.654

3.  Minimally invasive excision of lumbar epidural lipomatosis using a spinal endoscope.

Authors:  K Sairyo; T Sakai; K Higashino; B Hirao; S Katoh; N Yasui
Journal:  Minim Invasive Neurosurg       Date:  2008-02

4.  Diagnosis of the vertebral level from which low back or leg pain originates. A comparison of clinical evaluation, MRI and epiduroscopy.

Authors:  Hemmo A Bosscher; James E Heavner
Journal:  Pain Pract       Date:  2012-03-19       Impact factor: 3.183

5.  CT scan assessment of the pathway of the true lateral approach for transforaminal endoscopic lumbar discectomy: is It possible?

Authors:  D H Lee; N H Kim; J B Park; C J Hwang; C S Lee; Y T Kim; S J Kang; J M Rhee
Journal:  J Bone Joint Surg Br       Date:  2011-10

6.  Transforaminal posterolateral endoscopic discectomy with or without the combination of a low-dose chymopapain: a prospective randomized study in 280 consecutive cases.

Authors:  Thomas Hoogland; Michael Schubert; Boris Miklitz; Agnes Ramirez
Journal:  Spine (Phila Pa 1976)       Date:  2006-11-15       Impact factor: 3.468

7.  Endoscope-assisted thoracolumbar lateral corpectomy.

Authors:  Claude Carozzo; Pierre Maitre; Jean-Pierre Genevois; Pierre-Alexandre Gabanou; Didier Fau; Eric Viguier
Journal:  Vet Surg       Date:  2011-07-19       Impact factor: 1.495

8.  Extended endoscopic transphenoidal approach for tuberculum sellae meningiomas.

Authors:  Savas Ceylan; Kenan Koc; Ihsan Anık
Journal:  Acta Neurochir (Wien)       Date:  2010-09-07       Impact factor: 2.216

9.  Endoscopic approach to colloid cysts.

Authors:  A Zohdi; S El Kheshin
Journal:  Minim Invasive Neurosurg       Date:  2006-10

10.  Radiologic Anatomy of the Lumbar Interlaminar Window and Surgical Considerations for Lumbar Interlaminar Endoscopic and Microsurgical Disc Surgery.

Authors:  Zakir Sakçı; Mehmet Reşid Önen; Elif Fidan; Yunus Yaşar; Hikmet Uluğ; Sait Naderi
Journal:  World Neurosurg       Date:  2018-03-14       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.